Suppr超能文献

社区药店应对 COVID-19 大流行的准备情况。

Pandemic preparedness of community pharmacies for COVID-19.

机构信息

Dr., Pharmaceutical Management and Economics, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt; Dr., Pharmaceutical Management and Economics, Faculty of Pharmacy, Jazan University, Jazan, Saudi Arabia.

Dr., Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom.

出版信息

Res Social Adm Pharm. 2021 Jan;17(1):1888-1896. doi: 10.1016/j.sapharm.2020.05.009. Epub 2020 May 11.

Abstract

BACKGROUND

Community pharmacies provide an important healthcare service, which is broadly established, and constitutes the preferred and initial contact for members of the community. The significant value of community pharmacies was further highlighted during the COVID-19 pandemic crisis.

OBJECTIVE

The assessment of community pharmacies preparedness for the COVID-19 pandemic.

METHODS

A cross-sectional interview survey of 1018 community pharmacies working in four regions of Egypt (South, East, Centre, and North). Data collection was conducted from 8-19 April 2020.

RESULTS

Availability of personal protective equipment (PPE) and medication was better than alcohol (70% conc.). Home delivery services were available in 49.1% of pharmacies. Infection control measures covering interactions between staff were in place in up to 99.5% of pharmacies. Conversely, there was less frequent availability of contactless payment (29.1%), hand sanitizers (62.1%) or masks (86.5%) for customer use, or a separate area for patients with suspected COVID-19 (64%). Verbal customer education (90.4%) was used preferably to written (81.3%). Despite high clinical knowledge and awareness (97.6%-99.2%), only 8.8% of pharmacists had reported suspected COVID-19 cases, however this varied significantly with pharmacist demographics (geographic region P < 0.001; pandemic training p < 0.001; position p = 0.019; age p = 0.046).

CONCLUSIONS

Government and policymakers strive to mitigate the shortage of PPE and medication. More attention should be given to infection control measures around interactions between staff and customers to ensure community pharmacists are fit and able to provide continuity in their important role. Educating customers using regularly-updated posters, banners or signs will contribute to decreasing contact with patients, and reducing the number and duration of visits to the pharmacy. Pandemic preparedness of community pharmacists must also extend to reporting procedures. By avoiding under-reporting or over-reporting, community pharmacists will contribute to accurate monitoring of the national spread of infection.

摘要

背景

社区药房提供了一项重要的医疗服务,该服务广泛建立,并构成了社区成员首选和最初的联系方式。在 COVID-19 大流行危机期间,社区药房的重要价值进一步凸显。

目的

评估社区药房应对 COVID-19 大流行的准备情况。

方法

对埃及四个地区(南部、东部、中部和北部)的 1018 家社区药房进行了横断面访谈调查。数据收集于 2020 年 4 月 8 日至 19 日进行。

结果

个人防护设备 (PPE) 和药物的供应情况好于酒精 (70%浓度)。有 49.1%的药房提供上门送货服务。覆盖员工之间互动的感染控制措施在多达 99.5%的药房得到实施。相反,较少的药房提供非接触式支付 (29.1%)、洗手液 (62.1%) 或口罩 (86.5%) 供顾客使用,或为疑似 COVID-19 患者设立单独区域 (64%)。口头客户教育 (90.4%) 优先于书面教育 (81.3%)。尽管临床知识和意识水平很高 (97.6%-99.2%),但只有 8.8%的药剂师报告了疑似 COVID-19 病例,但这与药剂师的人口统计学特征差异显著 (地理位置 P < 0.001;大流行培训 P < 0.001;职位 P = 0.019;年龄 P = 0.046)。

结论

政府和政策制定者努力缓解个人防护设备和药物的短缺。应更加关注员工与顾客之间互动的感染控制措施,以确保社区药剂师身体健康,有能力继续发挥其重要作用。通过定期更新海报、横幅或标志向顾客进行教育,将有助于减少与患者的接触,并减少去药房的次数和时间。社区药剂师的大流行准备工作还必须延伸到报告程序。通过避免漏报或错报,社区药剂师将有助于准确监测全国感染的传播情况。

相似文献

1
Pandemic preparedness of community pharmacies for COVID-19.
Res Social Adm Pharm. 2021 Jan;17(1):1888-1896. doi: 10.1016/j.sapharm.2020.05.009. Epub 2020 May 11.
2
Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey.
Res Social Adm Pharm. 2021 Jan;17(1):1832-1837. doi: 10.1016/j.sapharm.2020.07.006. Epub 2020 Jul 9.
3
Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
Res Social Adm Pharm. 2021 Jan;17(1):1819-1824. doi: 10.1016/j.sapharm.2020.03.012. Epub 2020 Mar 26.
5
Community pharmacy practice related to the COVID-19 pandemic: barriers and facilitators.
Int J Pharm Pract. 2022 Jun 25;30(3):226-234. doi: 10.1093/ijpp/riac002.
6
Community pharmacy during the COVID-19 pandemic: a cross-sectional study.
Przegl Epidemiol. 2020;74(4):620-633. doi: 10.32394/pe.74.53.
7
Crisis management in community pharmacies during a pandemic.
Res Social Adm Pharm. 2024 Sep;20(9):940-948. doi: 10.1016/j.sapharm.2024.06.010. Epub 2024 Jun 24.
9
Emergency preparedness and response (EP&R) by pharmacy professionals in India: Lessons from the COVID-19 pandemic and the way forward.
Res Social Adm Pharm. 2021 Jan;17(1):2018-2022. doi: 10.1016/j.sapharm.2020.04.028. Epub 2020 Apr 25.
10
Coping with the burden of the COVID-19 pandemic: a cross-sectional study of community pharmacists from Serbia.
BMC Health Serv Res. 2021 Apr 6;21(1):304. doi: 10.1186/s12913-021-06327-1.

引用本文的文献

3
Experience and Learning from the COVID-19 Pandemic in Portugal: Perceptions of Community Pharmacy Professionals.
Port J Public Health. 2023 Aug 30;41(2):122-131. doi: 10.1159/000531446. eCollection 2023 Sep.
5
Global overview of pharmacist and community pharmacy actions to address COVID-19: A scoping review.
Explor Res Clin Soc Pharm. 2023 Jun;10:100261. doi: 10.1016/j.rcsop.2023.100261. Epub 2023 Apr 12.
6
Impact of the COVID-19 pandemic on pharmacy practice and on the provision of pharmaceutical care: A cross-sectional study among community pharmacists.
J Med Access. 2023 Mar 31;7:27550834231161145. doi: 10.1177/27550834231161145. eCollection 2023 Jan-Dec.
8
Communication openness and nosocomial infection reporting: the mediating role of team cohesion.
BMC Health Serv Res. 2022 Nov 24;22(1):1416. doi: 10.1186/s12913-022-08646-3.
9
Readiness and willingness of Malaysian community pharmacists in providing vaccination services.
J Pharm Policy Pract. 2022 Nov 12;15(1):81. doi: 10.1186/s40545-022-00478-0.
10
Development and validation of a lockdown preparedness scale: Understanding lockdown preparedness through a social vulnerability perspective.
Int J Disaster Risk Reduct. 2022 Nov;82:103367. doi: 10.1016/j.ijdrr.2022.103367. Epub 2022 Oct 13.

本文引用的文献

1
Psychological stress of medical staffs during outbreak of COVID-19 and adjustment strategy.
J Med Virol. 2020 Oct;92(10):1962-1970. doi: 10.1002/jmv.25914. Epub 2020 Jun 29.
2
Epidemiological trends of COVID-19 epidemic in Italy over March 2020: From 1000 to 100 000 cases.
J Med Virol. 2020 Oct;92(10):1956-1961. doi: 10.1002/jmv.25908. Epub 2020 May 12.
3
Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):465-471. doi: 10.15585/mmwr.mm6915e4.
4
Psychological status of medical workforce during the COVID-19 pandemic: A cross-sectional study.
Psychiatry Res. 2020 Jun;288:112936. doi: 10.1016/j.psychres.2020.112936. Epub 2020 Apr 4.
5
COVID-19 in Africa.
Nat Hum Behav. 2020 May;4(5):436-437. doi: 10.1038/s41562-020-0870-5.
6
An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China.
Science. 2020 May 8;368(6491):638-642. doi: 10.1126/science.abb6105. Epub 2020 Mar 31.
7
How behavioural science data helps mitigate the COVID-19 crisis.
Nat Hum Behav. 2020 May;4(5):438. doi: 10.1038/s41562-020-0866-1.
8
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.
9
Epidemiological data from the COVID-19 outbreak, real-time case information.
Sci Data. 2020 Mar 24;7(1):106. doi: 10.1038/s41597-020-0448-0.
10
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验